Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
van der Vaart Sandra D | EVP, Chief Legal Officer | May 14 '24 | Sale | 210.83 | 2,000 | 421,655 | 5,637 | May 16 08:02 AM | ANDERSON KERRII B | Director | May 02 '24 | Sale | 200.10 | 250 | 50,025 | 15,722 | May 02 04:29 PM | ANDERSON KERRII B | Director | Apr 30 '24 | Sale | 204.13 | 250 | 51,034 | 15,972 | May 02 04:29 PM | Wilkinson Peter J | SVP, Chief Accounting Officer | Apr 29 '24 | Sale | 204.33 | 2,439 | 498,358 | 2,087 | May 01 06:29 PM | Schroeder Mark S | EVP, Pres Diagnostics & COO | Apr 01 '24 | Sale | 217.29 | 6,477 | 1,407,387 | 5,036 | Apr 03 08:35 AM | Summy Amy B. | EVP, Chief Marketing Officer | Apr 01 '24 | Sale | 217.29 | 3,500 | 760,515 | 3,975 | Apr 03 08:34 AM | van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 28 '24 | Sale | 216.74 | 3,553 | 770,077 | 7,637 | Mar 29 05:54 PM | Schroeder Mark S | EVP, Pres Diagnostics & COO | Mar 07 '24 | Option Exercise | 117.09 | 2,119 | 248,114 | 10,084 | Mar 11 08:59 AM | Schroeder Mark S | EVP, Pres Diagnostics & COO | Mar 07 '24 | Sale | 218.45 | 5,048 | 1,102,736 | 5,036 | Mar 11 08:59 AM | Summy Amy B. | EVP, Chief Marketing Officer | Mar 07 '24 | Sale | 218.45 | 227 | 49,588 | 3,859 | Mar 11 08:56 AM | EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 21 '24 | Option Exercise | 163.63 | 14,054 | 2,299,656 | 58,099 | Feb 22 03:05 PM | EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 21 '24 | Sale | 215.97 | 34,504 | 7,451,866 | 23,595 | Feb 22 03:05 PM | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | Feb 21 '24 | Sale | 215.49 | 500 | 107,745 | 3,401 | Feb 22 03:04 PM | van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 13 '24 | Sale | 226.45 | 237 | 53,669 | 7,637 | Feb 15 08:32 AM | van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 08 '24 | Sale | 222.06 | 259 | 57,514 | 7,637 | Feb 09 12:19 PM | van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 05 '24 | Sale | 220.57 | 193 | 42,570 | 7,637 | Feb 06 03:47 PM | Wilkinson Peter J | SVP, Chief Accounting Officer | Nov 16 '23 | Sale | 210.71 | 1,384 | 291,627 | 2,087 | Nov 20 12:23 PM | ANDERSON KERRII B | Director | Aug 08 '23 | Sale | 211.57 | 5,000 | 1,057,832 | 15,275 | Aug 10 08:55 AM | van der Vaart Sandra D | EVP, Chief Legal Officer | Jun 29 '23 | Sale | 240.00 | 212 | 50,880 | 7,605 | Jul 03 11:52 AM |
|